Global Swine Pneumonia Market – Industry Trends and Forecast to 2030

Análise e dimensão do mercado da pneumonia suína

O aparecimento da gripe suína é geralmente súbito e afeta a maioria dos suínos. A pneumonia é muito frequente nos suínos e a incidência pode variar entre 19% a 79%. Está provado que os antibacterianos injetáveis ​​são o melhor tratamento para os sinais de pneumonia suína. O diagnóstico correcto das inúmeras causas de pneumonia é essencial para o tratamento adequado de cada animal e para o maneio, controlo e prevenção da pneumonia nos rebanhos suínos.

A Data Bridge Market Research analisa que o mercado da pneumonia suína, que era de 523,06 milhões de dólares em 2022, subiria para 859,18 milhões de dólares até 2030 e deverá passar por um CAGR de 6,40% durante o período de previsão de 2023 a 2030. Além do conhecimento sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de doentes, análise de pipeline, análise de preços e enquadramento regulamentar.

Âmbito e segmentação do mercado da pneumonia suína

Definição de mercado

A pneumonia suína é uma doença do trato respiratório inferior que afeta a saúde dos suínos. Esta doença pode causar inflamação pulmonar, infecção bacteriana e enorme mortalidade nos suínos, bem como um encargo financeiro para a indústria suína. A pneumonia nos porcos é tipicamente caracterizada por tosse e pancadas. De acordo com numerosos estudos, as doenças respiratórias dos suínos são uma combinação de várias doenças infecciosas e uma das principais causas de morte nos suínos de creche.

Dinâmica global do mercado da pneumonia suína

Motoristas

• Aumento da prevalência de pneumonia suína

Tem havido uma incidência crescente de pneumonia suína que está a aumentar o crescimento do mercado. Os processos pneumónicos foram presenciados em 73,1% dos animais. Consistiam principalmente em broncopneumonia cranioventral (CBP) (46,3%) e pleurite (17,6%). Além disso, a pneumonia broncointersticial (67,4%) foi prevalente e, ocasionalmente, combinada (27,9%) com pneumonia intersticial (PI). Verificou-se que a pneumonia é comum nos suínos e a incidência varia entre 19% a 79%, com base na região, sistema de produção ou sistema de pontuação de lesões pulmonares utilizado. Esta prevalência crescente resultou em processos de tratamento mais elevados para esta doença. Assim, este fator leva ao crescimento do mercado.

• Métodos de diagnóstico variados para a pneumonia suína

São utilizados vários sinais de métodos de diagnóstico para os processos de tratamento precoce da pneumonia. Os sinais clínicos típicos envolvem tosse, respiração rápida, temperatura elevada e exames post-mortem. Outros métodos, como os exames laboratoriais que envolvem a serologia e a microbiologia, são essenciais para identificar as possíveis causas. Assim, todos estes exames são importantes para o diagnóstico desta doença.

Oportunidades

• Aumentando a disponibilidade de processos de tratamento variados

Normalmente, a pneumonia nos porcos envolve uma infeção combinada de vírus e bactérias secundárias. No que diz respeito ao seu tratamento, são recomendados antibióticos de largo espectro, como a OTC, a penicilina-estreptomicina ou a amoxicilina. A injeção é também adequada e deve ser aplicada diariamente durante 3 a 4 dias. Por vezes, também são preferidos os CTC ou OTC na água e os medicamentos na ração a 600g/tonelada. A cobertura antibiótica é essencial durante pelo menos 14 a 21 dias. Estão disponíveis vários medicamentos para o tratamento, como a espectinomicina, lincomicina, tiamulina, clortetraciclina, tilosina e oxitetraciclina. Assim, este fator impulsiona o crescimento do mercado.  

• Aumento das aprovações de vacinas e investigação para a pneumonia suína

There are varied research activities carried out concerning vaccine production that boosts market growth. For instance, the RespiSure vaccine is approved for healthy swine vaccination to help prevent chronic pneumonia caused by Mycoplasma hyopneumoniae. It can be administered as early as one week of age with a booster shot two weeks later. This vaccine is suitable for pregnant swine, which may be safely vaccinated 6 and 2 weeks after farrowing. Thus, this factor escalates the market growth.

Restraints/Challenges

• Lack of Skilled Veterinarians

A lack of professional and skilled veterinarians who can handle pneumonia in pigs can lead to market obstruction. This very sensitive disease can affect majorly if not treated properly. Not all professionals can handle the pigs with the utmost knowledgeable treatment methods. Thus, this factor impedes market growth.  

This swine pneumonia market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the swine pneumonia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Swine Pneumonia Market Scope

The swine pneumonia market is segmented on the basis of diagnosis, treatment, mode of consultation, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

• Serologic Tests
• Polymerase Chain Reaction (PCR) Test
• Others

Treatment

• Vaccination
• Antibiotics
• Antibacterial
• Others

Mode of Consultation

• Over-the-Counter (OTC)
• Prescription

End Use

• Veterinary Hospitals
• Veterinary Specialty Clinics
• Others

Distribution Channel

• Veterinary Hospital Pharmacy
• Retail Pharmacy
• Veterinary Research Institute
• Others

Swine Pneumonia Market Regional Analysis/Insights

The swine pneumonia market is analyzed and market size insights and trends are provided by diagnosis, treatment, mode of consultation, end user and distribution channel as referenced above.

The countries covered in the swine pneumonia market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to grow during the forecast period of the swine pneumonia market because of the increasing occurrence of swine pneumonia, which further lead to the increased vaccination demand in this region. Furthermore, the high development of healthcare infrastructure will further boost this region's market's growth rate.

North America dominates the market in the forecast period because of the increasing awareness about vaccination among animal owners and increasing healthcare expenditure in this region. Furthermore, the presence of major market players will further boost the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The swine pneumonia market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for swine pneumonia market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the swine pneumonia market. The data is available for historic period 2011-2021.

Competitive Landscape and Swine Pneumonia Market Share Analysis

The swine pneumonia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to swine pneumonia market.

Some of the major players operating in the swine pneumonia market are:

• Sanofi (France)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mallinckrodt (U.S.)
• Elanco (U.S.)
• Boehringer Ingelheim International GmbH. (Germany)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• Bayer AG (Germany)
• Lilly (U.S.)
•  Merck & Co., Inc. (U.S.)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Cipla Inc. (U.S.)
• Abbott (U.S.)
• AbbVie Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Lupin (India)

SKU-53909